CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and ApoptosisXiaoli Li, Weiying Zhou, Wenjun Li et al.|Frontiers in Pharmacology|2020Cited by 34
<p>The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct</p>Liangyuan Long, Weiying Zhou, Xiangnan Hu et al.|OncoTargets and Therapy|2020Cited by 13